Clinical Trial Update: APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating APN401 in patients with metastatic or unresectable melanoma, pancreatic cancer, renal cell carcinoma, and other solid tumors has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Pancreatic Cancer
• Renal Cell Carcinoma

Drugs mentioned

• APN401

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Recurrent Melanoma, Recurrent Pancreatic Cancer | Phase 1 | Status: COMPLETED